New Medications for Tardive Dyskinesia Treatment
Tardive dyskinesia (TD), a movement disorder triggered by prolonged antipsychotic use, affects thousands across the United States. Understanding its impact, innovative treatments, and management strategies is crucial for improving patient quality of life. Dive into the role of healthcare providers, emerging medications like Austedo XR, and other therapeutic advancements that can transform patient care and […]
2 minute read